Dr Robertson is a Consultant Clinical Oncologist in the NHS and an Honorary Clinical Senior Lecturer at the University of Edinburgh. Her research focuses on emerging therapies for glioblastoma and she is the chief investigator for the upcoming ADePT trial, a phase I/II study of a novel gene therapy for glioblastoma. She undertook her medical training at the University of Edinburgh and also has a PhD in glioma stem cell biology. Prior to her medical career, she did a degree in English at the University of Oxford.